News

Elicio Therapeutics (ELTX) announced the publication of follow-up data from the Phase 1 AMPLIFY-201 study evaluating ELI-002 in the peer-reviewed ...
EXACT Therapeutics AS ( ($DE:56F) ) has shared an update. EXACT Therapeutics announced that data from its ACTIVATE Phase 1 trial, focusing on ...
Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...
The first patient in Cohort 3, the fifth patient in the trial, has completed the first week of cycle 1 following the ...
Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.
In the Phase 1/1b trial, ficerafusp alfa in combination with pembrolizumab resulted in deep and durable anti-tumor activity with improved overall survival (OS) compared to historical benchmarks in ...
Successful Phase 1 trial data indicates a 31% confirmed response rate for ALLO-316 in patients with advanced or metastatic renal cell carcinoma (RCC), demonstrating significant clinical potential.
The Fantastic Four: First Steps has officially kicked off Phase 6, bringing Marvel's first family into the MCU and in their own universe (Earth-828), separate from the 'main' MCU universe (Earth-616).
Mailing Address 825 Eastlake Ave. E. Mailstop LG-350 Seattle, WA 98109-1024 In a phase 1 clinical trial, small groups of participants get a new drug, or a combination of several drugs, that has shown ...
OPM and Professor Peyrin-Biroulet, presented the phase 1 results at the United European Gastroenterology Week (UEGW) 2024 held from October 12 to 15, 2024 in Vienna, Austria.